GenIP (AIM:TEK), the AIM-listed provider of AI-driven services helping research organisations and corporations commercialise their innovations, told investors that its underlying indicators are positive despite a drop in comparatives.
It reported first-half revenue of $53,000, down from $76,000 a year earlier once a one-off Saudi Arabian contract is stripped from the previous numbers. That Saudi order, worth $368,000, accounted for 70.8% of total FY25 revenue.
Gross margin fell to 6% from 18%, and the adjusted EBITDA loss widened to $692,000 from $561,000, reflecting continued spending on platform development, sales infrastructure and international expansion against lower revenue.
The company ended the period with cash of $410,000, topped up by a $470,000 (£350,000) equity placing completed in April, with proceeds directed toward commercialisation, partnerships and product development.
GenIP struck a strategic alliance with Cardinal Intellectual Property in April to accelerate access to the US market, and expanded regional business development in Asia and Latin America.
Post-period, new customer orders came from Chile, the UK and North America, and the company signed a new Talent Search engagement contract in August.
"While first-half revenues reflect the absence of last year's exceptional contract, underlying indicators are positive and aligned with the Company's development stage," said chief executive Melissa Cruz.
She added that GenIP enters the second half with "a good pipeline, deeper client engagement and increasing industry recognition".
News Intelligence what this means for the company
GenIP's first-half revenue collapsed to $53,000 after a one-off $368,000 Saudi contract that had accounted for 71% of prior-year revenue failed to repeat. The absence of that exceptional order has compressed gross margin to 6% from 18% and widened the adjusted EBITDA loss to $692,000, despite a $470,000 equity raise in April meant to fund commercialisation and product development. Management points to a strengthening pipeline and new customer wins post-period, but the company enters the second half with only $410,000 cash and no visibility to revenue scale.
GenIP remains a pre-revenue-scale business dependent on pipeline conversion and new customer acquisition to justify its equity raise. The loss of a single contract that represented 71% of annual revenue underscores the company's exposure to lumpy, one-off deals and the absence of recurring revenue streams—a structural risk that persists until the AI-driven IP tools and services achieve material adoption among research organisations and corporates.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
